Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
Michal Kováč(Slovak University of Technology in Bratislava), Daniel Baumhoer(University Hospital of Basel)
Cited by 343
Related Papers
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
|Journal of Clinical Oncology|2015|419
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support
|Cancer Cell|2021|140
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemia
|Nature Communications|2024|25
Feasibility of multiomics tumor profiling for guiding treatment of melanoma
|Nature Medicine|2025|15